RADIOPHAMACEUTICALS ¤Ó KIT FOR LABELLING WITH 99mTc
 

Product

Ref./storage

Indications
(Posology)

Time between injection and examination

Radiochemical purity

Stability labelled product

COLLOID (Sulfur)

HEAPTOCIS
(TCK-1)
*12 months / RT

      1. Hepatic scintigraphy
       : 37~111 MBq/70 kg (1~3 mCi)
      2. Splenic scintigraphy
       : 74~111 MBq/70 kg (2~3 mCi)
      3. Bone marrow scintigraphy
       : 155 MBq/70 kg (4.2 mCi) 

1. Liver scanning : 20 min
2. Spleen scaning : 20 min
3. Bone marrow scanning : 1h

¡Ã95%

6h ./ RT

HSA
(Human serum Albumin)

VASCULOCIS
(TCK-2)
*12 months/2~8°C

      1. Static blood pool imaging
       : 111~185 MBq (3~5 mCi)
      2. Angiography
       : 370~740 MBq (10~20 mCi)
      3. Blood flow studies
       : 18.5~185 MBq (0.5~5 mCi)
      4. Ventriculography
       : 185~925 MBq (5~25 mCi)

Shortly

¡Ã95%

8h ./ RT

HAM
(Human albumin microspheres)

MICROCIS
(TCK-5)
*18 months/2~8°C

      1. Pulmonary perfusion scintigraphy
      2. Venoscintigraphy
       : 37~185 MBq/70kg (1~5 mCi)

Immediately

¡Ã95%

6h ./ RT

DTPA
(Diethylenetriaminepentaacetic acid)

PENTACIS
(TCK-6)
*12 months/2~8°C

      1. Intravenous use
         Renal scintigraphy
         - plasma : 1.8~3.7 MBq (0.05~0.1mCi)
         - scanning : 37~370MBq (1~10mCi)
         Brain scanning
         : 185~740 MBq (5~20mCi)
      2. Inhalation
         nebuliser : 50~1000MBq (13.5~27mCi)
         Lung : 50~100MBq (1.35~2.7mCi)
      3. Gastro-oesophageal : 10~20MBq (0.3~0.54mCi)

Brain static scanning
: 1h tp several hours
Renal sequent : immediately
Optimal static imaging : 1h

¡Ã95%

6h/2~8°C

HAA
(Macroaggregated albumin)

PULMOCIS
*24 months/2~8°C

      1. Pulmonary perfusion scintigraphy
          : 37~185MBq (1~5mCi)
      2. Venoscintigraphy
          : 37~185MBq (1~5mCi)

Immediately

¡Ã95%

8h/2~8°C

PYP
(Phyrophosphate)
= used for in vitro labelling of red blood cell with 99mTc

HEMATOCIS
(TCK-11)
*5 months / 2~8°C

      1. Blood pool scintigraphy
         : 890 MBq (740 to 925MBq) 24 mCi (20~25mCi)
      2. Blood volumn
         : 3MBq (1 to 5 MBq) 81 uCi (27 to 135 uCi)
      3. Spleen scintigraphy
         : 50MBq (20 to 70 MBq) 1.4 mCi (0.54 to 1.90 mCi)

Immediately after administration
of the 99mTc for spleen scintigraphy

labelling yield
¡Ã
95%

3h after labelling

DMSA
(Dimercaptosuccinic acid)

RENOCIS
(TCK-12)
*12 months/2~8°C

      Static (fubctional) renal scintigraphy
      : 30~120 MBq (0.8~3.2 mCi)

      1. Image acquisition L 1~3h
      2. Renal impairment : 6h
      3. Renal obstruction : 24h

¡Ã95%

6h ./ RT

PHYTATE

PHYTACIS
(TCK-18)
*6 months/2~8°C

      Hepatic scintigraphy
      : 37~100 MBq (1~2.7 mCi)

10~60 min

¡Ã95%

8h/2~8°C

DISIDA
(Diisopropy liminodiacetic acid)

CHOLECIS
(TCK-22)
*12 months/2~8°C

      Hepatobilary imaging
      Hepatobilary function studies
      : 150~300 MBq (4.1~8.1 mCi)

      1. Patients fasting
          : 6h prior examination
      2. Biliary visualisation
          : 5~20 min after injection
      3. Gall bladder : 10~40 min

¡Ã95%

4h/RT

DPD
(Diphosphono
Propanedicarboxylic acid)

TECEOS
(DPD)

      Bone scintigraphy
      : 500 MBq (13.5mCi) or 300~700 MBq (8~19mCi)

Late phase static scintigraphy should be performed not earlier than 2 hours

¡Ã95%

8h/RT

IMPORTANT : Read package leaflet before using the kit
"Availability of the products, in the different countries, according to thr registration status"